CD13-Mediated Pegylated Carboxymethyl Chitosan-Capped Mesoporous Silica Nanoparticles for Enhancing the Therapeutic Efficacy of Hepatocellular Carcinoma

CD13-Mediated Pegylated Carboxymethyl Chitosan-Capped Mesoporous Silica Nanoparticles for Enhancing the Therapeutic Efficacy of Hepatocellular Carcinoma

Liver cancer, especially hepatocellular carcinoma, is an important cause of cancer-related death, and its incidence is increasing worldwide. Nano drug delivery systems have shown great promise in the treatment of cancers. In order to improve their therapeutic efficacy, it is very important to realiz...

Full description

Bibliographic Details
Main Authors: Jinhu Liu, Weiwei Mu, Tong Gao, Yuxiao Fang, Na Zhang, Yongjun Liu
Format: Article
Language:English
Published: MDPI AG 2023-01-01
Series:Pharmaceutics
Subjects:
mesoporous silica nanoparticle
NGR peptide
pegylated carboxymethyl chitosan
triggered release
hepatocellular carcinoma
Online Access:https://www.mdpi.com/1999-4923/15/2/426

Similar Items

Similar Items